FDA permits marketing of artificial intelligence-based device to detect certain diabetes

FDA permits marketing of artificial intelligence-based device to detect certain diabetes

  • April 13, 2018
Table of Contents

FDA permits marketing of artificial intelligence-based device to detect certain diabetes

The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.

Source: fda.gov

Share :
comments powered by Disqus

Related Posts

Depthwise separable convolutions for machine learning

Depthwise separable convolutions for machine learning

Convolutions are an important tool in modern deep neural networks (DNNs). This post is going to discuss some common types of convolutions, specifically regular and depthwise separable convolutions. My focus will be on the implementation of these operation, showing from-scratch Numpy-based code to compute them and diagrams that explain how things work.

Read More